Ionotropic glutamate-like receptor delta2 binds D-serine and glycine.
The orphan glutamate-like receptor GluRdelta2 is predominantly expressed in Purkinje cells of the central nervous system. The classification of GluRdelta2 to the ionotropic glutamate receptor family is based on sequence similarities, because GluRdelta2 does not form functional homomeric glutamate-gated ion channels in transfected cells. Studies in GluRdelta2(-/-) knockout mice as well as in mice with naturally occurring mutations in the GluRdelta2 gene have demonstrated an essential role of GluRdelta2 in cerebellar long-term depression, motor learning, motor coordination, and synaptogenesis. However, the lack of a known agonist has hampered investigations on the function of GluRdelta2. In this study, the ligand-binding core of GluRdelta2 (GluRdelta2-S1S2) was found to bind neutral amino acids such as D-serine and glycine, as demonstrated by isothermal titration calorimetry. Direct evidence for binding of D-serine and structural rearrangements in the binding cleft of GluRdelta2-S1S2 is provided by x-ray structures of GluRdelta2-S1S2 in its apo form and in complex with D-serine. Functionally, D-serine and glycine were shown to inactivate spontaneous ion-channel conductance in GluRdelta2 containing the lurcher mutation (EC(50) values, 182 and 507 microM, respectively). These data demonstrate that the GluRdelta2 ligand-binding core is capable of binding ligands and that cleft closure of the ligand-binding core can induce conformational changes that alter ion permeation.
Naur
Peter
P
Biostructural Research Unit, Department of Medicinal Chemistry, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark.
Hansen
Kasper B
KB
Kristensen
Anders S
AS
Dravid
Shashank M
SM
Pickering
Darryl S
DS
Olsen
Lars
L
Vestergaard
Bente
B
Egebjerg
Jan
J
Gajhede
Michael
M
Traynelis
Stephen F
SF
Kastrup
Jette S
JS
D000818:Animals; D001665:Binding Sites; D005998:Glycine / Q000378:metabolism*; D007700:Kinetics; D008024:Ligands; D051379:Mice; D018345:Mice, Knockout; D008958:Models, Molecular; D011485:Protein Binding; D011487:Protein Conformation; D017470:Receptors, Glutamate / Q000737:chemistry / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D012694:Serine / Q000378:metabolism*; D014961:X-Ray Diffraction
D008024:Ligands; D017470:Receptors, Glutamate; C107913:glutamate receptor delta 2; D012694:Serine; D005998:Glycine
Nat Neurosci. 2000 Apr;3(4):315-22
10725919
J Neurosci. 2000 Aug 15;20(16):5973-80
10934245
Neuron. 2000 Oct;28(1):165-81
11086992
Nature. 2002 Feb 14;415(6873):793-8
11823786
Eur J Neurosci. 2002 Oct;16(8):1507-16
12405964
J Med Chem. 2003 Jan 16;46(2):214-21
12519060
Brain Res Mol Brain Res. 2003 Jan 31;110(1):27-37
12573530
Eur J Neurosci. 2003 Apr;17(8):1581-90
12752376
EMBO J. 2003 Jun 16;22(12):2873-85
12805203
Nat Neurosci. 2003 Aug;6(8):869-76
12833050
Nat Neurosci. 2003 Aug;6(8):803-10
12872125
J Am Chem Soc. 2003 Dec 3;125(48):14859-66
14640663
J Neurosci. 2004 May 26;24(21):4941-51
15163686
Cerebellum. 2004;3(2):89-93
15233575
FEBS Lett. 1993 Jan 11;315(3):318-22
8422924
Biochem Biophys Res Commun. 1993 Dec 30;197(3):1267-76
7506541
J Neurosci. 1995 Mar;15(3 Pt 2):2533-46
7891187
Cell. 1995 Apr 21;81(2):245-52
7736576
Neuroreport. 1995 Feb 15;6(3):524-6
7766857
Neurosci Lett. 1995 Mar 24;188(2):89-92
7792064
Brain Res Dev Brain Res. 1996 Apr 30;92(2):147-55
8738121
J Neurosci. 1997 Mar 1;17(5):1604-15
9030620
Nature. 1997 Aug 21;388(6644):769-73
9285588
J Neurosci. 1998 Jul 15;18(14):5517-28
9651232
Crit Rev Neurobiol. 2004;16(3):187-224
15701057
FEBS Lett. 2005 Feb 14;579(5):1154-60
15710405
J Neurosci. 2005 Feb 23;25(8):2146-56
15728855
Nature. 2005 Nov 10;438(7065):185-92
16281028
Mol Pharmacol. 2005 Dec;68(6):1510-23
16131614
J Neurosci. 2006 Apr 26;26(17):4559-66
16641235
Ann Neurol. 2006 Oct;60(4):476-80
17068790